Arkolith/Insider Trading/VRCA/Form 4

Rieger Jayson

CEO and President, DirectorVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Nov 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2024Gift(G)50K—$0883K
Nov 22, 2024Buy(P)281K——833K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 22, 2024Buy(P)140K——140K
Nov 22, 2024Buy(P)140K——140K

Transaction Codes

G
Gift
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-027711) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML